Your browser doesn't support javascript.
loading
Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence.
Moody, Sarah; Senkin, Sergey; Islam, S M Ashiqul; Wang, Jingwei; Nasrollahzadeh, Dariush; Cortez Cardoso Penha, Ricardo; Fitzgerald, Stephen; Bergstrom, Erik N; Atkins, Joshua; He, Yudou; Khandekar, Azhar; Smith-Byrne, Karl; Carreira, Christine; Gaborieau, Valerie; Latimer, Calli; Thomas, Emily; Abnizova, Irina; Bucciarelli, Pauline E; Jones, David; Teague, Jon W; Abedi-Ardekani, Behnoush; Serra, Stefano; Scoazec, Jean-Yves; Saffar, Hiva; Azmoudeh-Ardalan, Farid; Sotoudeh, Masoud; Nikmanesh, Arash; Poustchi, Hossein; Niavarani, Ahmadreza; Gharavi, Samad; Eden, Michael; Richman, Paul; Campos, Lia S; Fitzgerald, Rebecca C; Ribeiro, Luis Felipe; Soares-Lima, Sheila Coelho; Dzamalala, Charles; Mmbaga, Blandina Theophil; Shibata, Tatsuhiro; Menya, Diana; Goldstein, Alisa M; Hu, Nan; Malekzadeh, Reza; Fazel, Abdolreza; McCormack, Valerie; McKay, James; Perdomo, Sandra; Scelo, Ghislaine; Chanudet, Estelle; Humphreys, Laura.
Afiliación
  • Moody S; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Senkin S; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Islam SMA; Moores Cancer Centre, UC San Diego Health, La Jolla, CA, USA.
  • Wang J; Department of Cellular and Molecular Medicine, University of California, La Jolla, CA, USA.
  • Nasrollahzadeh D; Department of Bioengineering, University of California, La Jolla, CA, USA.
  • Cortez Cardoso Penha R; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Fitzgerald S; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Bergstrom EN; Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.
  • Atkins J; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • He Y; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Khandekar A; Moores Cancer Centre, UC San Diego Health, La Jolla, CA, USA.
  • Smith-Byrne K; Department of Cellular and Molecular Medicine, University of California, La Jolla, CA, USA.
  • Carreira C; Department of Bioengineering, University of California, La Jolla, CA, USA.
  • Gaborieau V; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Latimer C; Moores Cancer Centre, UC San Diego Health, La Jolla, CA, USA.
  • Thomas E; Department of Cellular and Molecular Medicine, University of California, La Jolla, CA, USA.
  • Abnizova I; Department of Bioengineering, University of California, La Jolla, CA, USA.
  • Bucciarelli PE; Moores Cancer Centre, UC San Diego Health, La Jolla, CA, USA.
  • Jones D; Department of Cellular and Molecular Medicine, University of California, La Jolla, CA, USA.
  • Teague JW; Department of Bioengineering, University of California, La Jolla, CA, USA.
  • Abedi-Ardekani B; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Serra S; Evidence Synthesis and Classification Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Scoazec JY; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Saffar H; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Azmoudeh-Ardalan F; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Sotoudeh M; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Nikmanesh A; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Poustchi H; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Niavarani A; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
  • Gharavi S; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Eden M; University Health Network, Toronto, Ontario, Canada.
  • Richman P; Department Laboratory Medicine and Pathology, Gustave Roussy, Paris, France.
  • Campos LS; Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Fitzgerald RC; Liver Transplantation Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Ribeiro LF; Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.
  • Soares-Lima SC; Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.
  • Dzamalala C; Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.
  • Mmbaga BT; Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.
  • Shibata T; Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.
  • Menya D; Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, UK.
  • Goldstein AM; Histopathology Department, Hemel Hempstead General Hospital, Hemel Hempstead, UK.
  • Hu N; West Suffolk NHS Foundation Trust, Bury St Edmunds, UK.
  • Malekzadeh R; MRC Cancer Unit, University of Cambridge, Cambridge, UK.
  • Fazel A; Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
  • McCormack V; Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
  • McKay J; University of Malawi, Zomba, Malawi.
  • Perdomo S; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre & Kilimanjaro Christian Medical University College, Moshi, Tanzania.
  • Scelo G; Division of Cancer Genomics, National Cancer Centre Research Institute, Tokyo, Japan.
  • Chanudet E; Moi University, Mombasa, Kenya.
  • Humphreys L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA.
Nat Genet ; 53(11): 1553-1563, 2021 11.
Article en En | MEDLINE | ID: mdl-34663923
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas de Esófago / Mutación Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: America do sul / Asia / Brasil / Europa Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas de Esófago / Mutación Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: America do sul / Asia / Brasil / Europa Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido